232 related articles for article (PubMed ID: 15233378)
21. Inhibition of brevetoxin binding to the voltage-gated sodium channel by gambierol and gambieric acid-A.
Inoue M; Hirama M; Satake M; Sugiyama K; Yasumoto T
Toxicon; 2003 Mar; 41(4):469-74. PubMed ID: 12657316
[TBL] [Abstract][Full Text] [Related]
22. Brevetoxins bind to multiple classes of sites in rat brain synaptosomes.
Edwards RA; Trainer VL; Baden DG
Brain Res Mol Brain Res; 1992 Jun; 14(1-2):64-70. PubMed ID: 1323018
[TBL] [Abstract][Full Text] [Related]
23. Marine brevetoxin induces IgE-independent mast cell activation.
Hilderbrand SC; Murrell RN; Gibson JE; Brown JM
Arch Toxicol; 2011 Feb; 85(2):135-41. PubMed ID: 20549194
[TBL] [Abstract][Full Text] [Related]
24. Intrinsic potency of synthetically prepared brevetoxin cysteine metabolites BTX-B2 and desoxyBTX-B2.
Dechraoui MY; Wang Z; Ramsdell JS
Toxicon; 2007 Nov; 50(6):825-34. PubMed ID: 17689582
[TBL] [Abstract][Full Text] [Related]
25. Monitoring brevetoxins during a Gymnodinium breve red tide: comparison of sodium channel specific cytotoxicity assay and mouse bioassay for determination of neurotoxic shellfish toxins in shellfish extracts.
Dickey R; Jester E; Granade R; Mowdy D; Moncreiff C; Rebarchik D; Robl M; Musser S; Poli M
Nat Toxins; 1999; 7(4):157-65. PubMed ID: 10797644
[TBL] [Abstract][Full Text] [Related]
26. Preservation of brevetoxins in Southwest Florida coastal sediments.
Javaruski J; Adhikari PL; Muller J; Parsons ML
Harmful Algae; 2022 May; 114():102222. PubMed ID: 35550300
[TBL] [Abstract][Full Text] [Related]
27. Ability of some plant extracts, traditionally used to treat ciguatera fish poisoning, to prevent the in vitro neurotoxicity produced by sodium channel activators.
Boydron-Le Garrec R; Benoit E; Sauviat MP; Lewis RJ; Molgó J; Laurent D
Toxicon; 2005 Nov; 46(6):625-34. PubMed ID: 16165180
[TBL] [Abstract][Full Text] [Related]
28. Complex behavior of marine animal tissue extracts in the competitive binding assay of brevetoxins with rat brain synaptosomes.
Whitney PL; Delgado JA; Baden DG
Nat Toxins; 1997; 5(5):193-200. PubMed ID: 9496378
[TBL] [Abstract][Full Text] [Related]
29. Neurotoxic shellfish poisoning.
Watkins SM; Reich A; Fleming LE; Hammond R
Mar Drugs; 2008; 6(3):431-55. PubMed ID: 19005578
[TBL] [Abstract][Full Text] [Related]
30. Fate and distribution of brevetoxin (PbTx) following lysis of Karenia brevis by algicidal bacteria, including analysis of open A-ring derivatives.
Roth PB; Twiner MJ; Wang Z; Bottein Dechraoui MY; Doucette GJ
Toxicon; 2007 Dec; 50(8):1175-91. PubMed ID: 17905402
[TBL] [Abstract][Full Text] [Related]
31. Photoaffinity labeling of the brevetoxin receptor on sodium channels in rat brain synaptosomes.
Trainer VL; Thomsen WJ; Catterall WA; Baden DG
Mol Pharmacol; 1991 Dec; 40(6):988-94. PubMed ID: 1661842
[TBL] [Abstract][Full Text] [Related]
32. A cellular target for the lipophilic toxins from Karenia brevisulcata.
Truman P
Toxicon; 2007 Aug; 50(2):251-5. PubMed ID: 17490696
[TBL] [Abstract][Full Text] [Related]
33. Initial evaluation of the effects of aerosolized Florida red tide toxins (brevetoxins) in persons with asthma.
Fleming LE; Kirkpatrick B; Backer LC; Bean JA; Wanner A; Dalpra D; Tamer R; Zaias J; Cheng YS; Pierce R; Naar J; Abraham W; Clark R; Zhou Y; Henry MS; Johnson D; Van De Bogart G; Bossart GD; Harrington M; Baden DG
Environ Health Perspect; 2005 May; 113(5):650-7. PubMed ID: 15866779
[TBL] [Abstract][Full Text] [Related]
34. A rapid assay for the brevetoxin group of sodium channel activators based on fluorescence monitoring of synaptoneurosomal membrane potential.
David LS; Plakas SM; El Said KR; Jester EL; Dickey RW; Nicholson RA
Toxicon; 2003 Aug; 42(2):191-8. PubMed ID: 12906890
[TBL] [Abstract][Full Text] [Related]
35. Brevetoxin metabolism and elimination in the Eastern oyster (Crassostrea virginica) after controlled exposures to Karenia brevis.
Plakas SM; Wang Z; El Said KR; Jester EL; Granade HR; Flewelling L; Scott P; Dickey RW
Toxicon; 2004 Nov; 44(6):677-85. PubMed ID: 15501294
[TBL] [Abstract][Full Text] [Related]
36. Brevetoxin derivatives act as partial agonists at neurotoxin site 5 on the voltage-gated Na+ channel.
LePage KT; Baden DG; Murray TF
Brain Res; 2003 Jan; 959(1):120-7. PubMed ID: 12480165
[TBL] [Abstract][Full Text] [Related]
37. Extraction and analysis of lipophilic brevetoxins from the red tide dinoflagellate Karenia brevis.
Twiner MJ; Bottein Dechraoui MY; Wang Z; Mikulski CM; Henry MS; Pierce RH; Doucette GJ
Anal Biochem; 2007 Oct; 369(1):128-35. PubMed ID: 17662954
[TBL] [Abstract][Full Text] [Related]
38. The relationship of brevetoxin 'length' and A-ring functionality to binding and activity in neuronal sodium channels.
Gawley RE; Rein KS; Jeglitsch G; Adams DJ; Theodorakis EA; Tiebes J; Nicolaou KC; Baden DG
Chem Biol; 1995 Aug; 2(8):533-41. PubMed ID: 9383457
[TBL] [Abstract][Full Text] [Related]
39. Brevetoxin (PbTx-2) influences the redox status and NPQ of Karenia brevis by way of thioredoxin reductase.
Chen W; Colon R; Louda JW; Del Rey FR; Durham M; Rein KS
Harmful Algae; 2018 Jan; 71():29-39. PubMed ID: 29306394
[TBL] [Abstract][Full Text] [Related]
40. Brevetoxins, unique activators of voltage-sensitive sodium channels, bind to specific sites in rat brain synaptosomes.
Poli MA; Mende TJ; Baden DG
Mol Pharmacol; 1986 Aug; 30(2):129-35. PubMed ID: 2426567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
